Results 41 to 50 of about 13,013 (192)

Loss of KMT2D induces prostate cancer ROS-mediated DNA damage by suppressing the enhancer activity and DNA binding of antioxidant transcription factor FOXO3

open access: yesEpigenetics, 2019
Histone methyltransferase KMT2D has diverse functions and distinct mechanisms in different cancers. Although we have previously found KMT2D serves as an oncogene that promotes tumor growth and metastasis in prostate cancer (PCa), the functions and ...
Shidong Lv   +7 more
doaj   +1 more source

DataSheet_1_Lysine methyltransferase Kmt2d regulates naive CD8+ T cell activation-induced survival.pdf

open access: yes, 2023
Lysine specific methyltransferase 2D (Kmt2d) catalyzes the mono-methylation of histone 3 lysine 4 (H3K4me1) and plays a critical role in regulatory T cell generation via modulating Foxp3 gene expression.
Qian Yang (300330)   +12 more
core   +1 more source

Elucidating the Role of KMT2D in HER2+ Breast Cancer [PDF]

open access: yes, 2022
Breast cancer is the second leading cause of cancer-related deaths among women in the US. Histone modifications are common epigenetic changes that have been implicated in several breast cancers, including HER2+ breast cancers.
Ma, Emily
core   +1 more source

The defining DNA methylation signature of Kabuki syndrome enables functional assessment of genetic variants of unknown clinical significance

open access: yesEpigenetics, 2017
Kabuki syndrome (KS) is caused by mutations in KMT2D, which is a histone methyltransferase involved in methylation of H3K4, a histone marker associated with DNA methylation.
Erfan Aref-Eshghi   +8 more
doaj   +1 more source

Expression pattern of Kmt2d in murine craniofacial tissues

open access: yesGene Expression Patterns, 2019
Formation of the calvaria is a multi-staged process and is regulated by multiple genetic factors. Disruption of normal calvarial development usually causes craniosynostosis, a prevalent birth defect characterized by premature fusion of calvarial bone. Recent studies have identified mutations of KMT2D allele in patients with craniosynostosis, indicating
Chunmin, Dong   +5 more
openaire   +3 more sources

Neonatal Kabuki syndrome caused by KMT2D mutation: A case report

open access: yesMedicine, 2023
Background: Kabuki syndrome (KS) is an autosomal dominant inherited syndrome that involves multiple organs and systems. Gene mutation is the main cause of KS. The reported mutations in X-linked histone H3 lysine 4 methylase (KMT2D) and KDM6A genes are 2 relatively clear pathogenic pathways. In this paper, we report a case of KS
Zhang Li, Zou Ning
openaire   +2 more sources

Chromatin regulation at the intersection of estrogen receptor and PI3K pathways in breast cancer

open access: yesMolecular & Cellular Oncology, 2019
Estrogen Receptor (ER) and the phosphoinositide 3-kinase (PI3K) pathways participate in regulatory crosstalk in breast cancer. We identified that chromatin regulation is at the intersection of oncogenic PI3K and ER.
Pau Castel, Eneda Toska
doaj   +1 more source

KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [PDF]

open access: yesGenes & Development, 2018
Epithelial tissues rely on a highly coordinated balance between self-renewal, proliferation, and differentiation, disruption of which may drive carcinogenesis. The epigenetic regulator KMT2D (MLL4) is one of the most frequently mutated genes in all cancers, particularly epithelial cancers, yet its normal function in these tissues is unknown.
Lin-Shiao, Enrique   +11 more
openaire   +2 more sources

Inhibition of KDM1A activity restores adult neurogenesis and improves hippocampal memory in a mouse model of Kabuki syndrome

open access: yesMolecular Therapy: Methods & Clinical Development, 2021
Kabuki syndrome (KS) is a rare cause of intellectual disability primarily caused by loss-of-function mutations in lysine-specific methyltransferase 2D (KMT2D), which normally adds methyl marks to lysine 4 on histone 3.
Li Zhang   +12 more
doaj   +1 more source

The Baseline Molecular Profile of Late Relapse: Identifying Drivers of Delayed Recurrence in DLBCL [PDF]

open access: yesHematol Oncol
Hematological Oncology, Volume 44, Issue 6, November 2026.
Masar M   +18 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy